CorMedix CRMD
NASDAQ CRMD
$8.00 +0.21 (+2.70%)
As of: Oct 22, 2026 · 10:52 AM EDT

CorMedix (CRMD) Non-Current Debt (2012 - 2024)

Updated

Analysis

CorMedix (CRMD) Non-Current Debt (2012 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,166.78 Bn 1,135.37 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 635.34 Bn 553.86 Bn 17.26 Bn 37.34 Bn
3 AbbVie 503.48 Bn 476.60 Bn 12.70 Bn 62.48 Bn
4 Merck 377.08 Bn 331.46 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 304.13 Bn 268.12 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 267.48 Bn 241.16 Bn 12.86 Bn 23.68 Bn
7 Amgen 241.75 Bn 197.15 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 194.09 Bn 168.29 Bn 6.22 Bn 23.83 Bn
9 Pfizer 172.59 Bn 119.24 Bn 10.94 Bn 60.50 Bn
10 CorMedix 625.59 Mn -26.93 Mn 77.13 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 200,000.00
Dec 31, 2012 383,865.00
API Access

CorMedix Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=CRMD&period=max&api_key=YOUR_API_KEY